HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gérard Lina Selected Research

Panton-Valentine leukocidin

1/2014Kineret®/IL-1ra blocks the IL-1/IL-8 inflammatory cascade during recombinant Panton Valentine Leukocidin-triggered pneumonia but not during S. aureus infection.
8/2013Severe leukopenia in Staphylococcus aureus-necrotizing, community-acquired pneumonia: risk factors and impact on survival.
5/2013The staphylococcal toxin Panton-Valentine Leukocidin targets human C5a receptors.
12/2012Ceftobiprole efficacy in vitro against Panton-Valentine leukocidin production and in vivo against community-associated methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
1/2011Panton-Valentine leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infections.
1/2009Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains.
10/2008Association of necrotizing pneumonia with Panton-Valentine leukocidin-producing Staphylococcus aureus, regardless of methicillin resistance.
11/2007Pediatric bone and joint infections caused by Panton-Valentine leukocidin-positive Staphylococcus aureus.
9/2006Severe osteoarticular infection associated with Panton-Valentine leukocidin-producing Staphylococcus aureus.
11/2005Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gérard Lina Research Topics

Disease

16Infections
01/2022 - 11/2003
5Septic Shock (Toxic Shock Syndrome)
10/2018 - 07/2004
5Necrotizing Pneumonia
01/2014 - 11/2005
4Tuberculosis (Tuberculoses)
02/2021 - 04/2014
3Cystic Fibrosis (Mucoviscidosis)
01/2022 - 01/2012
3Inflammation (Inflammations)
12/2021 - 07/2012
3Pneumonia (Pneumonitis)
01/2014 - 08/2005
3Sepsis (Septicemia)
12/2012 - 12/2006
3Abscess
01/2012 - 12/2006
2Nontuberculous Mycobacterium Infections
01/2022 - 01/2022
2Bacteremia
12/2015 - 01/2012
2Lung Injury
01/2014 - 07/2012
2Wounds and Injuries (Trauma)
03/2012 - 12/2008
2Ulcer
03/2012 - 12/2008
2Diabetic Foot
03/2012 - 12/2008
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2021
1Diabetes Mellitus
10/2021
1Urinary Tract Infections (Urinary Tract Infection)
10/2021
1Chronic Kidney Failure (Chronic Renal Failure)
10/2021
1Neoplasms (Cancer)
10/2021
1Legionnaires' Disease (Legionnaire's Disease)
09/2020
1Lung Diseases (Lung Disease)
12/2018
1Allergic Bronchopulmonary Aspergillosis
09/2017
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2015
1Alzheimer Disease (Alzheimer's Disease)
04/2013
1Central Nervous System Infections (Central Nervous System Infection)
04/2013
1Porcine Reproductive and Respiratory Syndrome (PRRS)
04/2013
1Osteomyelitis
12/2012
1Body Weight (Weight, Body)
12/2012
1Endocarditis
01/2012
1Endophthalmitis (Ophthalmia)
12/2009
1Soft Tissue Infections
01/2009
1Foot Ulcer
12/2008
1Blister (Bulla)
10/2008
1Osteoarthritis
09/2006
1Thrombosis (Thrombus)
09/2006
1Mastitis
11/2002

Drug/Important Bio-Agent (IBA)

11Panton-Valentine leukocidinIBA
01/2014 - 08/2005
4Anti-Bacterial Agents (Antibiotics)IBA
04/2014 - 09/2006
3Rifampin (Rifampicin)FDA LinkGeneric
02/2021 - 12/2012
3Pharmaceutical PreparationsIBA
04/2020 - 12/2015
3Leukocidins (Leukocidin)IBA
10/2018 - 08/2015
3InflammasomesIBA
01/2014 - 07/2012
2Virulence Factors (Pathogenicity Factors)IBA
12/2021 - 01/2012
2Isoniazid (Ftivazide)FDA LinkGeneric
02/2021 - 01/2018
2Linezolid (Zyvox)FDA Link
12/2015 - 12/2015
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2014 - 07/2012
2RNA (Ribonucleic Acid)IBA
01/2012 - 11/2002
1Immunoglobulin A (IgA)IBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1staphylococcal delta toxinIBA
12/2021
1AntigensIBA
09/2020
1Clindamycin (Cleocin)FDA LinkGeneric
10/2018
1Interleukin-8B ReceptorsIBA
01/2018
1Staphylococcal enterotoxin FIBA
01/2018
1Itraconazole (Sporanox)FDA LinkGeneric
09/2017
1Adrenal Cortex Hormones (Corticosteroids)IBA
09/2017
1CoagulaseIBA
12/2015
11,2- diarachidonoyl- glycero- 3- phosphocholineIBA
12/2015
1Methicillin (Metin)FDA Link
12/2015
1Interleukin-1 (Interleukin 1)IBA
01/2014
1Interleukin-8 (Interleukin 8)IBA
01/2014
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2014
1CytokinesIBA
04/2013
1FlagellinIBA
04/2013
1Interleukin-18 (Interleukin 18)IBA
04/2013
1Pattern Recognition ReceptorsIBA
04/2013
1ceftobiproleIBA
12/2012
1VancomycinFDA LinkGeneric
12/2012
1Peptides (Polypeptides)IBA
07/2012
1DNA (Deoxyribonucleic Acid)IBA
03/2012
1OligonucleotidesIBA
03/2012
1Indicators and Reagents (Reagents)IBA
11/2008
1leukotoxinIBA
12/2006
1Enterotoxins (Enterotoxin)IBA
07/2004
1SuperantigensIBA
07/2004
1Interferon-gamma (Interferon, gamma)IBA
11/2003

Therapy/Procedure

4Therapeutics
12/2018 - 11/2003
1Lung Transplantation
01/2022
1Stents
10/2021
1Menstrual Hygiene Products (Menstrual Pad)
01/2018
1Drug Therapy (Chemotherapy)
12/2015
1Kidney Transplantation
12/2011
1Vitrectomy
12/2009
1Filtering Surgery
10/2008
1Resuscitation
08/2005
1Hip Prosthesis
11/2003